Response Mechanism Of ICB Among Patients With Breast Cancer And Novel Approach To Predicting Therapeutic Efficacy

Source :: Legal Monitor Worldwide. May 24, 2021
Publication Year :: 2021
Abstract: Immunotherapeutic drugs, as represented by immune-checkpoint blockade (ICB), have achieved tremendous success in curing various tumors in recent years, thus improving the survival and life quality of some tumor patients [...]

Subjects :: Cancer -- Adjuvant treatment
Cancer patients -- Drug therapy
Immunotherapy -- Health aspects
Breast cancer -- Drug therapy
Business, international
Law

Tools